Articles from NeueHealth

NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSENEUE), the value-driven healthcare company, today announced that it has entered into a definitive merger agreement pursuant to which the Company will be acquired by an affiliate of New Enterprise Associates (“NEA”) at an enterprise value of approximately $1.3 billion. Upon completion of the transaction, NeueHealth will become a privately held company with the flexibility and resources to continue advancing its value-driven, consumer-centric care model.

NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSENEUE), the value-driven healthcare company, today reported financial results for its third quarter ended September 30, 2024.

NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSENEUE), the value-driven healthcare company, today announced that Centrum Health, one of the Company’s value-driven clinic brands, became a wholly owned subsidiary through the Company’s acquisition of the remaining 25% equity interest of the business that it did not already own. This action simplifies NeueHealth’s corporate structure, streamlining operations to support its ongoing focus on advancing its value-driven, consumer-centric care model.

NeueHealth, Inc. ("NeueHealth") (NYSENEUE), the value-driven healthcare company, today announced it will report Third Quarter financial results before the financial markets open on Thursday, November 7, 2024, followed by a conference call at 8:00 AM Eastern Time.

NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSENEUE), the value-driven healthcare company, today reported financial results for its second quarter ended June 30, 2024.

NeueHealth, Inc. ("NeueHealth") (NYSENEUE), the value-driven healthcare company, today announced it will report Second Quarter financial results before the financial markets open on Wednesday, August 7, 2024, followed by a conference call at 8:00 AM Eastern Time.

NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSENEUE), the value-driven healthcare company, today announced that it entered into a secured loan facility for up to $150 million with Hercules Capital, Inc. NYSE: HTGCNYSEHTGC)

NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSENEUE), the value-driven healthcare company, today announced that on June 12, 2024, the Company received a written notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that the Company no longer satisfies the continued listing standards set forth under Section 802.01B of the NYSE’s Listed Company Manual. The notice cited that the Company’s average market capitalization over a consecutive 30 trading-day period was less than $50 million and, at the same time, the Company’s last reported stockholders’ equity was less than $50 million. As of June 11, 2024, the 30 trading-day average market capitalization was approximately $49.7 million, and the company reported a stockholders’ deficit. The Company’s preferred stock, which had a value of $920.4 million as of March 31, 2024, is excluded from the average market capitalization as calculated by the NYSE. This notice does not impact the Company’s business operations.

NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSENEUE), the value-driven healthcare company, today reported financial results for its First Quarter ended March 31, 2024.

NeueHealth, Inc. ("NeueHealth") (NYSENEUE), the value-driven healthcare company, today announced it will report First Quarter financial results before the financial markets open on Wednesday, May 8, 2024, followed by a conference call at 8:00 AM Eastern Time.

NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSENEUE), the value-driven healthcare company, today announced that it entered into an incremental amendment to its credit facility with New Enterprise Associates (“NEA”) that increases the term loan commitment by $30 million on April 8, 2024. The proceeds of the incremental commitment are intended to be used for general corporate purposes, including to support the Company’s 2024 strategic priorities.

NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSENEUE), the value-driven healthcare company, today reported financial results for its fourth quarter and full year ended December 31, 2023.

NeueHealth, Inc. ("NeueHealth") (NYSENEUE), the value-driven healthcare company, today announced it will report Fourth Quarter financial results before the financial markets open on Wednesday, March 6, 2024, followed by a conference call at 8:00 AM Eastern Time.

Bright Health Group, Inc. (“Bright Health” or the “Company”) (NYSEBHG) today announced that it has adopted NeueHealth as its corporate brand name. This reflects the Company’s ongoing focus on its NeueHealth business, which will continue driving long-term sustainable growth of its value-driven, consumer-centric care model, thereby increasing access to high-quality healthcare for all populations across the ACA Marketplace, Medicare, and Medicaid. The Company’s common stock will begin trading under the new ticker symbol “NEUE” on the New York Stock Exchange (NYSE), effective January 29, 2024.